TVRD
Tvardi Therapeutics
TVRD
TVRD
42 hedge funds and large institutions have $6.59M invested in Tvardi Therapeutics in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 18 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
81% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 32
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Holders
42
Holding in Top 10
–
Calls
–
Puts
$2K
Top Buyers
| 1 | +$565K | |
| 2 | +$389K | |
| 3 | +$311K | |
| 4 |
CRC
Curi RMB Capital
Chicago,
Illinois
|
+$164K |
| 5 |
RG
Rathbones Group
Liverpool,
United Kingdom
|
+$67.1K |
Top Sellers
| 1 | -$524K | |
| 2 | -$343K | |
| 3 | -$128K | |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
-$103K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$97.4K |